StockData
Prestige Consumer Healthcare Inc. logo

Prestige Consumer Healthcare Inc. (PBH) stock

PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$50.62+2.40 (+4.98%)

Close on Nov 18, 2026Market cap $2.40BP/E 14.2Yield –

Prestige Consumer Healthcare total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Prestige Consumer Healthcare's total debt was $2.02B at Jun 30, 2026. For fiscal 2026 it was $993.95M, down 12.4% from the year before. Over ten years it grew -4.4% a year on average. The highest annual figure on record is $2.19B in fiscal 2017.

Annual total debt

PeriodPeriod endValueChange
FY2026Mar 31, 2026$993.95M-12.4%
FY2024Mar 31, 2024$1.14B-15.7%
FY2023Mar 31, 2023$1.35B-8.9%
FY2022Mar 31, 2022$1.48B-0.2%
FY2021Mar 31, 2021$1.48B-14.5%
FY2020Mar 31, 2020$1.73B-3.8%
FY2019Mar 31, 2019$1.80B-9.8%
FY2018Mar 31, 2018$1.99B-9.2%
FY2017Mar 31, 2017$2.19B+35.0%
FY2016Mar 31, 2016$1.63B+4.1%
FY2015Mar 31, 2015$1.56B+67.1%
FY2014Mar 31, 2014$934.41M-3.8%
FY2013Mar 31, 2013$970.90M-13.6%
FY2012Mar 31, 2012$1.12B+130.8%
FY2011Mar 31, 2011$486.95M–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$2.02B+83.4%
Q4 FY2026CQ1 2026Mar 31, 2026$993.95M-12.4%
Q3 FY2025CQ4 2024Dec 31, 2024$1.00B-17.4%
Q2 FY2025CQ3 2024Sep 30, 2024$1.06B-16.9%
Q1 FY2025CQ2 2024Jun 30, 2024$1.10B-17.3%
Q4 FY2024CQ1 2024Mar 31, 2024$1.14B-15.7%
Q3 FY2024CQ4 2023Dec 31, 2023$1.21B-16.0%
Q2 FY2024CQ3 2023Sep 30, 2023$1.28B-12.4%
Q1 FY2024CQ2 2023Jun 30, 2023$1.33B-10.7%
Q4 FY2023CQ1 2023Mar 31, 2023$1.35B-8.9%
Q3 FY2023CQ4 2022Dec 31, 2022$1.44B-7.1%
Q2 FY2023CQ3 2022Sep 30, 2022$1.46B-10.2%
Q1 FY2023CQ2 2022Jun 30, 2022$1.49B-3.6%
Q4 FY2022CQ1 2022Mar 31, 2022$1.48B-0.2%
Q3 FY2022CQ4 2021Dec 31, 2021$1.55B+0.1%
Q2 FY2022CQ3 2021Sep 30, 2021$1.62B+4.6%
Q1 FY2022CQ2 2021Jun 30, 2021$1.55B-4.6%
Q4 FY2021CQ1 2021Mar 31, 2021$1.48B-14.5%
Q3 FY2021CQ4 2020Dec 31, 2020$1.55B-9.0%
Q2 FY2021CQ3 2020Sep 30, 2020$1.55B-11.7%
Q1 FY2021CQ2 2020Jun 30, 2020$1.62B-8.9%
Q4 FY2020CQ1 2020Mar 31, 2020$1.73B-3.8%
Q3 FY2020CQ4 2019Dec 31, 2019$1.70B-7.7%
Q2 FY2020CQ3 2019Sep 30, 2019$1.75B-7.5%
Q1 FY2020CQ2 2019Jun 30, 2019$1.78B-10.8%
Q4 FY2019CQ1 2019Mar 31, 2019$1.80B-9.8%
Q3 FY2019CQ4 2018Dec 31, 2018$1.84B-10.3%
Q2 FY2019CQ3 2018Sep 30, 2018$1.90B-9.4%
Q1 FY2019CQ2 2018Jun 30, 2018$1.99B-7.1%
Q4 FY2018CQ1 2018Mar 31, 2018$1.99B-9.2%
Q3 FY2018CQ4 2017Dec 31, 2017$2.05B+45.0%
Q2 FY2018CQ3 2017Sep 30, 2017$2.09B+41.4%
Q1 FY2018CQ2 2017Jun 30, 2017$2.15B–
Q4 FY2017CQ1 2017Mar 31, 2017$2.19B–
Q3 FY2017CQ4 2016Dec 31, 2016$1.42B–
Q2 FY2017CQ3 2016Sep 30, 2016$1.48B–

More Prestige Consumer Healthcare figures

See a number that looks wrong?